Inventor · disambiguated record
Albert Barnes Seymour
Also filed as: SEYMOUR ALBERT · SEYMOUR ALBERT B · SEYMOUR ALBERT BARNES
8 granted patents·10 pending applications·9 citations·filing 2001–2024
76Inventor score
Top patents by PatentIndex Score
18 records- 0190US10610606B2Adeno-associated virus compositions for PAH gene transfer and methods of use thereofHOMOLOGY MEDICINES INC·Filed 2019·Granted Apr 7, 2020·9 cites·35 claims
- 0271US2025090691A1Adeno-associated virus compositions for restoring pah gene function and methods of use thereofHOMOLOGY MEDICINES INC·Filed 2024·Application pending·0 cites
- 0366US2022325302A1Adeno-associated virus compositions for restoring pah gene function and methods of use thereofHOMOLOGY MEDICINES INC·Filed 2022·Application pending·0 cites
- 0465US12064486B2Adeno-associated virus compositions for PAH gene transfer and methods of use thereofHOMOLOGY MEDICINES INC·Filed 2020·Granted Aug 20, 2024·0 cites·20 claims
- 0564US12203094B2Adeno-associated virus compositions for restoring PAH gene function and methods of use thereofHOMOLOGY MEDICINES INC·Filed 2020·Granted Jan 21, 2025·0 cites·20 claims
- 0663US12076420B2Adeno-associated virus compositions for restoring PAH gene function and methods of use thereofHOMOLOGY MEDICINES INC·Filed 2021·Granted Sep 3, 2024·0 cites·18 claims
- 0762US11951183B2Adeno-associated virus compositions for PAH gene transfer and methods of use thereofHOMOLOGY MEDICINES INC·Filed 2020·Granted Apr 9, 2024·0 cites·18 claims
- 0858US2019256867A1Adeno-associated virus compositions for restoring pah gene function and methods of use thereofHOMOLOGY MEDICINES INC·Filed 2019·Application pending·0 cites
- 0955US2022204991A1Adeno-Associated Virus Compositions for ARSA Gene Transfer and Methods of Use ThereofHOMOLOGY MEDICINES INC·Filed 2021·Application pending·0 cites
- 1054US11059906B2Anti-CCL2 and anti-LOXL2 combination therapy for treatment of sclerodermaSHIRE HUMAN GENETIC THERAPIES·Filed 2014·Granted Jul 13, 2021·0 cites·4 claims
- 1151US2015158942A1Anti-ccl2 antibodies for treatment of sclerodermaSHIRE HUMAN GENETIC THERAPIES·Filed 2013·Application pending·0 cites
- 1250US2018179275A1Anti-ccl2 antibodies for treatment of sclerodermaSHIRE HUMAN GENETIC THERAPIES·Filed 2017·Application pending·0 cites
- 1347US12201657B2Adeno-associated virus compositions for restoring HBB gene function and methods of use thereofHOPE CITY·Filed 2018·Granted Jan 21, 2025·0 cites·3 claims
- 1446US11952585B2Methods of treating phenylketonuriaHOMOLOGY MEDICINES INC·Filed 2021·Granted Apr 9, 2024·0 cites·17 claims
- 1546US2003054381A1Genetic polymorphisms in the human neurokinin 1 receptor gene and their uses in diagnosis and treatment of diseasesPFIZER·Filed 2002·Application pending·0 cites
- 1645US2016289319A1Anti-ccl2 antibodies for treatment of sclerodermaSHIRE HUMAN GENETIC THERAPIES·Filed 2016·Application pending·0 cites
- 1742US2002025530A1PCR-based multiplex assay for determining haplotypeFiled 2001·Application pending·0 cites
- 1835US2002155474A1Methods and reagents for detecting increased risk of developing an inflammatory disorderFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Albert Barnes Seymour files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →